Bonomo, G.; Certo, F.; Grasso, E.; Fiumanò, G.; Barbagallo, D.; Caltabiano, R.; Broggi, G.; Magro, G.; Maugeri, A.; Agodi, A.;
et al. Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment. Brain Sci. 2025, 15, 428.
https://doi.org/10.3390/brainsci15050428
AMA Style
Bonomo G, Certo F, Grasso E, Fiumanò G, Barbagallo D, Caltabiano R, Broggi G, Magro G, Maugeri A, Agodi A,
et al. Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment. Brain Sciences. 2025; 15(5):428.
https://doi.org/10.3390/brainsci15050428
Chicago/Turabian Style
Bonomo, Giulio, Francesco Certo, Erica Grasso, Giuseppa Fiumanò, Davide Barbagallo, Rosario Caltabiano, Giuseppe Broggi, Gaetano Magro, Andrea Maugeri, Antonella Agodi,
and et al. 2025. "Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment" Brain Sciences 15, no. 5: 428.
https://doi.org/10.3390/brainsci15050428
APA Style
Bonomo, G., Certo, F., Grasso, E., Fiumanò, G., Barbagallo, D., Caltabiano, R., Broggi, G., Magro, G., Maugeri, A., Agodi, A., Latteri, F., Sotoparra, H., Buscema, G., Spatola, C., Pluchino, A., & Barbagallo, G. M. V.
(2025). Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment. Brain Sciences, 15(5), 428.
https://doi.org/10.3390/brainsci15050428
